References

  1. Garnier B, Simon E, Dumont T, Sellal S, Stricker M, Chassagne J-F. Les carcinomes cutanés basocellulaires méritent-ils leur réputation de tumeurs à faible malignité ?. Rev Stomatol Chir Maxillofac. 2005; 106(1):16-21. PubMed | Google Scholar

  2. Bialy T, Whalen J, Veledar E, Lafreniere D, Spiro J,Chartier T, Chen SC. Mohs micrographic surgery vs traditional surgical excision a cost comparition analysis. Arch Dematol. 2004;140(6):736-42. PubMed | Google Scholar

  3. Limmer BL. Nonmelanoma skin cancer: today’s epidemic. Tex Med. 2001; 97(2):56-8. PubMed | Google Scholar

  4. Agence nationale d’accréditation et d’évaluation en Santé (Anaes). Carcinome basocellulaire : Recommandations pour la pratique clinique. Ann Dermatol Venereol. 2004; 131(6-7 Pt2):680-756. PubMed | Google Scholar

  5. National Health Medical Research Council. Non melanoma skin cancer: guidelines for treatment and management in Australia. Clinical practice guidelines. Canberra: NHMRC, 2002. PubMed | Google Scholar

  6. Société Marocaine de Cancérologie. Manuel de cancérologie clinique : connaissances fondamentales et pratiques. 2013. Rabat. Al Maârif Al Jadida. PubMed | Google Scholar

  7. Gloster HM, Brodland DG Jr. The epidemiology of skin cancer. Dermatol Surg. 1996; 22(3):217-26. PubMed | Google Scholar

  8. Basset-Seguin N, Dreno B, Grob JJ. Tumeurs cutanées épithéliales et mélaniques: Carcinomes épithéliaux. Ann Dermatol Venereol. 2002; 129(10 Suppl):S132-6. PubMed | Google Scholar

  9. Mora RG, Robins P. Basal cell carcinoma in the center of the face: special diagnostic, prognostic and therapeutic considerations. J Dermatol Surg Oncol. 1978; 4(4):315-21. PubMed | Google Scholar

  10. Panje W, Ceilley R. The influence of embryology of the midface on the spread of epithelial malignancies. Laryngoscope. 1979 ; 89(12):1914-20. PubMed | Google Scholar

  11. Granier G, Agrici V, Habib F, Meunier L, Moustey C, Marty-Double C. La chirurgie micrographique de Mohs dans la prise en charge des carcinomes basocellulaires. Ann Pathol. 2007; 27(2):74–9. PubMed | Google Scholar

  12. Bénateau H, Verneuil L, Labbé D, Dompmartin A, Compère J-F. Tumeurs épidermiques de la région cervicofaciale et du cuir chevelu. Encycl Méd Chir, Chirurgie Orale et Maxillo-faciale.2002 ; 22-062-E-10, 12 p. PubMed | Google Scholar

  13. Guichard S (1999). Chirurgie des tumeurs cutanées. Encycl Méd Chir, Techniques chirurgicales – Chirurgie plastique reconstructrice et esthétique.1999 ; 45-140, 17 p. PubMed | Google Scholar

  14. Staub G, Revol M, May P, Bayol J-C, Verola O, Servant J-M. Marges d’exérèse chirurgicale et taux de récidive des carcinomes cutanés : Etude prospective de 844 cas. Annales de chirurgie plastique esthétique. 2008 ; 53(5):389-98. PubMed | Google Scholar

  15. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. J Dermatol Surg Oncol. 1991; 17(9):720-6. PubMed | Google Scholar

  16. Nseir A, Estève E. Carcinomes basocellulaires. Presse Med. 2008 ; 37(10):1466-73. PubMed | Google Scholar

  17. Pascal RR, Hobby LW, Lattes R, Crikelair GF. Prognosis of ‘‘incompletely excised ’’ versus ‘‘completely excised’’ basal cell carcinoma. Plast Reconstr Surg.1968; 41(4):328-32. PubMed | Google Scholar

  18. Liu FF, Maki E, Warde P, Payne D, Fitzpatrick P. A management approach to incompletely excised basal cell carcinomas of skin. Int J Radiat Oncol Biol Phys. 1991; 20(3):423-8. PubMed | Google Scholar

  19. Gooding CA, White G, Yatsuhashi M. Significance of marginal extension in excised basal-cell carcinoma. N Engl J Med. 1965; 273(17):923-4. PubMed | Google Scholar

  20. Wilson AW, Howsam G, Santhanam V, Macpherson D, Grant J, Pratt CA, Townend JV. Surgical management of incompletely excised basal cell carcinomas of the head and neck. Br J Oral Maxillofac Surg. 2004; 42(4):311-4. PubMed | Google Scholar

  21. De Silva S, Dellon A. Recurrence rate of positive margin basal cell carcinoma: results of a five-year prospective study. Journal of Surgical Oncology. 1985; 28(1):72-4. PubMed | Google Scholar

  22. Boulinguez S, Grison-Tabone C, Lamant L, Valmary S, Viraben R, Bonnetblanc JM, Bédane C. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol. 2004; 151(3):623-6. PubMed | Google Scholar

  23. Smith V, Walton S. Treatment of Facial Basal Cell Carcinoma: A Review. J Skin Cancer. 2011;2011:380371. PubMed | Google Scholar

  24. Mohs F. Chemosurgery for the microscopically controlled excision of skin cancer. Journal of Surgical Oncology. 1971; 3(3):257–67. PubMed | Google Scholar

  25. Abide JM, Nahai F, Bennett RG. The meaning of surgical margins. Plast Reconstr Surg. 1984; 73(3):492-7. PubMed | Google Scholar

  26. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 1999; 141(3):415-23. PubMed | Google Scholar

  27. Paoli J, Daryoni S, Wennberg AM, Mölne L, Gillstedt M, Miocic M, Stenquist B. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm Venereol. 2011; 91(6):689-93. PubMed | Google Scholar

  28. Smeets NW, Kuijpers DI, Nelemans P, Ostertag JU, Verhaegh ME, Krekels GA, Neumann HA. Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br J Dermatol. 2004; 151(1):141-7. PubMed | Google Scholar

  29. Wennberg AM, Larkö O, Stenquist B. Five-year results of Mohs’ micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol. 1999; 79(5):370-2. PubMed | Google Scholar

  30. Mosterd K, Krekels GA, Nieman FH, Ostertag JU, Essers BA, Dirksen CD, Steijlen PM, Vermeulen A, Neumann H, Kelleners-Smeets NW. Surgical excision versus Mohs micrographic surgery for primary and recurrent basal cell carcinoma of the face: a prospective randomised controlled trial with 5-years’ follow-up. Lancet Oncol. 2008; 9(12):1149-56. PubMed | Google Scholar